期刊文献+

聚乙二醇化蛋白类药物的药代动力学

下载PDF
导出
摘要 聚乙二醇化蛋白质药物的研究开发是改善蛋白药物药代动力学、药效学、毒性和安全性的重要研究领域。本文通过文献资料分析聚乙二醇和聚乙二醇-蛋白质类药物与药代动力学(包括分布、代谢、消除)的关系,认识聚乙二醇化药物的药代动力学对聚乙二醇化蛋白质药物的有效性、毒性、安全性的影响。本文利用聚乙二醇化集落刺激因子长效制剂在比格犬的药代动力学与药效学和聚乙二醇化重组集成干扰素变异体在猕猴的药代动力学研究结果。
出处 《解放军药学学报》 CAS 2012年第1期1-5,共5页 Pharmaceutical Journal of Chinese People's Liberation Army
基金 国家973项目 No.2010CB735602 2012CB724002 国家重大新药创制项目 No.2011ZX09102-009-002 2012ZX09304-002
  • 相关文献

参考文献2

二级参考文献21

  • 1Reddy KR. Controlled- release, pegylated, liposomal formulations: new mechanisms in the delivery of injectable drugs. Ann Pharmacother, 2000, 34:915-923.
  • 2Delgado C, Francis GE, Fisher D. The uses and properties of PEG- linked problems. Crit Rev Ther Drug Carrier Syst,1992, 9:249-304.
  • 3Fung WJ, Porter JE, Bailon P. Strategies for the preparation and characterization of polyethelyne glycol (PEG) conjugated pharmaceutical proteins. Polymers Preprint, 1997, 38: 565 -566.
  • 4Kozlowski A, Charles SA, Harris MJ. Development of pegylated interferons for the treatment of chronic hepatitis C. BioDrugs, 2001, 15:419-429.
  • 5Perry CM, Jarvis B. Peginterferon - a - 2a (40kD) ; A review of its use in the management of chronic hepatitis C. Drugs,2001, 61:2263-2288.
  • 6Lam NP, Neumann AU, Gretch DR, et al. Dose dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa. Hepatology, 1997, 26(1):226-231.
  • 7LamNP, NeumannAU, GretchDR, et al. Dose - dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa. Hepatology, 1997, 26: 226-231.
  • 8Zeuzem S, Heathcote JE, Martin N, et al. Peginterferon alfa2a (40 kDa) monotherapy: a novel gent for chronic hepatitis C therapy. Expert Opin Investig D, 2001, 10:2201-2213.
  • 9Buti M, Sanchez- Avila F, Lurie Y, et al. Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2different doses of peginterferon alfa - 2b plus ribavirin. Hepatology, 2002, 35:930-936.
  • 10Zeuzem S, Feinman SV, Rasenack J, et al. Peginterferon alfa - 2a in patients with chronic hepatitis C. N Engl J Med, 2000,343:1666 - 1672.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部